Solventum Corp. stock falls Friday, underperforms market
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
GEN6m
Thermo Fisher Scientific Agreed to Acquire Solventum’s Purification and Filtration Business
The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.
Nelson Peltz’s Trian Pushes Solventum to Further Simplify Business
Activist investor Trian Fund Management plans to push Solventum to separate more of its businesses after the company’s $4.1 ...
Solventum forecasts annual profit above estimates on strong surgical product sales
M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.
Solventum price target raised to $75 from $73 at Wells Fargo
Wells Fargo raised the firm’s price target on Solventum (SOLV) to $75 from $73 and keeps an Equal Weight rating on the shares. The Q4 beat was ...
Solventum Stock Jumps After $4.1B Deal With Thermo Fisher
Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said ...
Solventum In The Early Stages Of A Multiyear Turnaround Effort
Solventum faces significant challenges in its turnaround, including slow-growing core businesses, share loss, and margin ...
Solventum price target raised to $84 from $75 at Piper Sandler
Piper Sandler raised the firm’s price target on Solventum (SOLV) to $84 from $75 and keeps a Neutral rating on the shares. The firm notes ...
Solventum Corp (SOLV) Q4 2024 Earnings Call Highlights: Strong EPS and Strategic Moves Amid ...
Solventum Corp (SOLV) reports robust earnings per share and strategic advancements, while navigating separation complexities and market headwinds.